IL-6 and the acute phase response in murine atherosclerosis

Li Song1, Christian Schindler

  • 1Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Atherosclerosis
|October 19, 2004
PubMed

Insights

Interleukin-6 (IL-6) and the acute phase response (APR) are not significant factors in the development of atherosclerosis. This study found minimal differences in lesion development in mice lacking IL-6, suggesting other factors are more critical in heart disease.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Genetics

Background:

  • C-reactive protein (CRP) and the acute phase response (APR) are linked to atherosclerotic heart disease.
  • Interleukin-6 (IL-6) regulates CRP and APR, and is also a potential heart disease risk factor.

Purpose of the Study:

  • To investigate the direct role of IL-6 in the development of atherosclerosis.
  • To determine if IL-6 and the APR significantly contribute to atherogenesis.

Main Methods:

  • Generated IL-6 knockout mice crossed with LDL receptor (LDL-R) knockout mice.
  • Evaluated atherosclerotic lesion development on Chow, Western, and Paigen diets.
  • Assessed APR gene expression in response to dietary challenges.

Main Results:

  • Paigen diet induced APR genes in LDL-R knockout mice, but not in IL-6/LDL-R knockout mice.
  • No significant differences in atherosclerotic lesion development were observed between LDL-R knockout and IL-6/LDL-R knockout mice.
  • Modest, non-statistically significant variations in lesion development were noted.

Conclusions:

  • IL-6 and the acute phase response may play a less critical role in atherogenesis than previously suggested.
  • Findings challenge the established significance of IL-6 in the development of atherosclerotic heart disease.

Related Concept Videos